$TKMR Recent News U.S. stocks tick up; Yahoo r
Post# of 144503
U.S. stocks tick up; Yahoo rallies 10:00 a.m. Today - Carla Mozee
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 8:52 a.m. Today - Barbara Kollmeyer
Fighting Ebola though investing: one firm’s approach 6:42 p.m. Oct. 21, 2014 - Wallace Witkowski
Small victories recorded in fight against Ebola 12:21 p.m. Oct. 20, 2014 - Russ Britt
Is there an Ebola bubble in these stocks? 3:21 p.m. Oct. 16, 2014 - Wallace Witkowski
U.S. stocks end Monday sharply lower on late selloff 4:25 p.m. Oct. 13, 2014 - Barbara Kollmeyer
Ebola stock trading volumes should raise red flags 3:07 p.m. Oct. 13, 2014 - Wallace Witkowski
CSX leads railroads higher; Fiat debuts in U.S. market 1:01 p.m. Oct. 13, 2014 - Sue Chang
Ebola stocks: 2 to sell, and 5 to consider buying 12:08 p.m. Oct. 13, 2014 - The Trading Deck
Ebola-related shares rally in premarket as Texas nurse tests positive 7:46 a.m. Oct. 13, 2014 - Ciara Linnane
Gap slumps on weak comparable sales; Ruby Tuesday surges 11:01 a.m. Oct. 9, 2014 - Sue Chang
U.S. to start screening for Ebola at five airports 6:25 p.m. Oct. 8, 2014 - Russ Britt
Costco up on earnings, GoPro slides on analyst downgrade 10:50 a.m. Oct. 8, 2014 - Joseph Adinolfi
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 8:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Ebola vaccine use likely to be confined, experts say 7:27 a.m. Oct. 8, 2014 - Russ Britt
Small-cap buckling and trap doors could make for a brutal earnings season 6:07 a.m. Oct. 8, 2014 - Shawn Langlois
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Tekmira shares slump as Leerink downgrades on valuation grounds 10:23 a.m. Oct. 6, 2014 - Ciara Linnane
Tekmira Pharmaceuticals downgraded to market perform at Leerink 9:00 a.m. Oct. 6, 2014 - Ciara Linnane
10 biggest market-moving events of the week 5:03 p.m. Oct. 3, 2014 - Philip van Doorn
Heavy Volume And Pre-Market Movement For Tekmira Pharmaceuticals (TKMR) 9:11 a.m. Today - TheStreet.com
Tekmira begins limited manufacturing of Ebola drug 2:10 a.m. Today - Seeking Alpha
Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock 11:18 a.m. Oct. 21, 2014 - TheStreet.com
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Tekmira Presents Data on Hepatitis B Candidate TKM-HBV - Analyst Blog 5:30 p.m. Oct. 16, 2014 - Zacks.com
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Tekmira Presents Results Of Preclinical Studies With Hepatitis B Therapeutic 2:31 p.m. Oct. 15, 2014 - benzinga.com
Irrational Ebola Fears: What To Do And What Not To Do 1:31 p.m. Oct. 15, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Ebola: Is The Cure Out There? 1:06 p.m. Oct. 14, 2014 - GuruFocus.com
Ebola: Don’t Buy Hazmat Suits-Maker Lakeland Industries (LAKE) 10:17 a.m. Oct. 14, 2014 - InvestorPlace.com
Tekmira And The Sad State Of Ebola Stocks 7:56 a.m. Oct. 14, 2014 - Seeking Alpha
Ebola Stocks: A Real Portfolio Killer 7:35 a.m. Oct. 13, 2014 - Seeking Alpha
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
'Fast Money' Recap: How to Trade in a Volatile Marketplace 5:00 a.m. Oct. 10, 2014 - TheStreet.com
Chimerix Falls as Ebola Patient on Brincidofovir Dies in US - Analyst Blog 4:30 p.m. Oct. 9, 2014 - Zacks.com
Tekmira Provides Periodic Update on TKM-Ebola Program 7:50 p.m. Oct. 21, 2014 - GlobeNewswire
Critical Alerts For Tesla Motors, Tekmira Pharmaceuticals, Gilead Sciences, 3D Systems and TASER International Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene 9:10 a.m. Oct. 15, 2014 - PR Newswire - PRF
Tekmira's Partner Reports Positive Clinical Data for LNP-Enabled Patisiran 12:45 a.m. Oct. 14, 2014 - GlobeNewswire
Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society 1:00 p.m. Oct. 9, 2014 - GlobeNewswire
Revised Guidance, Development Milestones, Appointment, Program Extension, and Event Schedules - Research Reports on Mylan, Tekmira, GSK, Cigna and WellPoint 9:00 a.m. Oct. 8, 2014 - PR Newswire - PRF
What's Next: Investors Place Ebola Pandemic Stock Bets 7:59 a.m. Oct. 6, 2014 - ACCESSWIRE
Tekmira to Present at BIO Investor Forum 11:45 p.m. Oct. 2, 2014 - GlobeNewswire
Tekmira Achieves $1.5 Million Development Milestone 7:00 p.m. Oct. 2, 2014 - GlobeNewswire
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:10 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:30 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:03 p.m. Aug. 12, 2014 - ACCESSWIRE